Changes to the Natural Killer Cell Repertoire after Therapeutic Hepatitis B DNA Vaccination

Background

Improvements to the outcome of adaptive immune responses could be achieved by inducing specific natural killer (NK) cell subsets which can cooperate with dendritic cells to select efficient T cell responses. We previously reported the induction or reactivation of T cell responses in chronic hepatitis B patients vaccinated with a DNA encoding hepatitis B envelope proteins during a phase I clinical trial.

Methodology/Principal Findings

In this study, we examined changes in the peripheral NK cell populations occurring during this vaccine trial using flow cytometry analysis. Despite a constant number of NK cells in the periphery, a significant increase in the CD56^bright population was observed after each vaccination and during the follow up. Among the 13 different NK cell markers studied by flow cytometry analysis, the expression of CD244 and NKG2D increased significantly in the CD56^bright NK population. The ex vivo CD107a expression by CD56^bright NK cells progressively increased in the vaccinated patients to reach levels that were significantly higher compared to chronically HBV-infected controls. Furthermore, modifications to the percentage of the CD56^bright NK cell population were correlated with HBV-specific T cell responses detected by the ELISPOT assay.

Conclusions/Significance

These changes in the CD56^bright population may suggest a NK helper effect on T cell adaptive responses. Activation of the innate and adaptive arms of the immune system by DNA immunization may be of particular importance to the efficacy of therapeutic interventions in a context of chronic infections.

Trial Registration

ClinicalTrials.gov {"type":"clinical-trial","attrs":{"text":"NCT00988767","term_id":"NCT00988767"}}NCT00988767     

Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response

Cholesterol-laden monocyte-derived macrophages are phagocytic cells characteristic of early and advanced atherosclerotic lesions. Interleukin-6 (IL-6) is a macrophage secretory product that is abundantly expressed in atherosclerotic plaques but whose precise role in atherogenesis is unclear. The capacity of macrophages to clear apoptotic cells, through the efferocytosis mechanism, as well as to reduce cellular cholesterol accumulation contributes to prevent plaque progression and instability. By virtue of its capacity to promote cellular cholesterol efflux from phagocyte-macrophages, ABCA1 was reported to reduce atherosclerosis. We demonstrated that lipid loading in human macrophages was accompanied by a strong increase of IL-6 secretion. Interestingly, IL-6 markedly induced ABCA1 expression and enhanced ABCA1-mediated cholesterol efflux from human macrophages to apoAI. Stimulation of ABCA1-mediated cholesterol efflux by IL-6 was, however, abolished by selective inhibition of the Jak-2/Stat3 signaling pathway. In addition, we observed that the expression of molecules described to promote efferocytosis, i.e. c-mer proto-oncogene-tyrosine kinase, thrombospondin-1, and transglutaminase 2, was significantly induced in human macrophages upon treatment with IL-6. Consistent with these findings, IL-6 enhanced the capacity of human macrophages to phagocytose apoptotic cells; moreover, we observed that IL-6 stimulates the ABCA1-mediated efflux of cholesterol derived from the ingestion of free cholesterol-loaded apoptotic macrophages. Finally, the treatment of human macrophages with IL-6 led to the establishment of an anti-inflammatory cytokine profile, characterized by an increased secretion of IL-4 and IL-10 together with a decrease of that of IL-1β. Taken together, our results indicate that IL-6 favors the elimination of excess cholesterol in human macrophages and phagocytes by stimulation of ABCA1-mediated cellular free cholesterol efflux and attenuates the macrophage proinflammatory phenotype. Thus, high amounts of IL-6 secreted by lipid laden human macrophages may constitute a protective response from macrophages to prevent accumulation of cytotoxic-free cholesterol. Such a cellular recycling of free cholesterol may contribute to reduce both foam cell formation and the accumulation of apoptotic bodies as well as intraplaque inflammation in atherosclerotic lesions.     

Structural and Functional Investigations of Matrilin-1 A-domains Reveal Insights into Their Role in Cartilage ECM Assembly

Matrilin-1 is expressed predominantly in cartilage and co-localizes with matrilin-3 with which it can form hetero-oligomers. We recently described novel structural and functional features of the matrilin-3 A-domain (M3A) and demonstrated that it bound with high affinity to type II and IX collagens. Interactions preferentially occurred in the presence of Zn²⁺ suggesting that matrilin-3 has acquired a requirement for specific metal ions for activation and/or molecular associations. To understand the interdependence of matrilin-1/-3 hetero-oligomers in extracellular matrix (ECM) interactions, we have extended these studies to include the two matrilin-1 A-domains (i.e. M1A1 and M1A2 respectively). In this study we have identified new characteristics of the matrilin-1 A-domains by describing their glycosylation state and the effect of N-glycan chains on their structure, thermal stability, and protein-protein interactions. Initial characterization revealed that N-glycosylation did not affect secretion of these two proteins, nor did it alter their folding characteristics. However, removal of the glycosylation decreased their thermal stability. We then compared the effect of different cations on binding between both M1A domains and type II and IX collagens and showed that Zn²⁺ also supports their interactions. Finally, we have demonstrated that both M1A1 domains and biglycan are essential for the association of the type II·VI collagen complex. We predict that a potential role of the matrilin-1/-3 hetero-oligomer might be to increase multivalency, and therefore the ability to connect various ECM components. Differing affinities could act to regulate the integrated network, thus coordinating the organization of the macromolecular structures in the cartilage ECM.     

ICEEc2, a New Integrative and Conjugative Element Belonging to the pKLC102/PAGI-2 Family,Identified in Escherichia coli Strain BEN374

The diversity of the Escherichia coli species is in part due to the large number of mobile genetic elements that are exchanged between strains. We report here the identification of a new integrative and conjugative element (ICE) of the pKLC102/PAGI-2 family located downstream of the tRNA gene pheU in the E. coli strain BEN374. Indeed, this new region, which we called ICEEc2, can be transferred by conjugation from strain BEN374 to the E. coli strain C600. We were also able to transfer this region into a Salmonella enterica serovar Typhimurium strain and into a Yersinia pseudotuberculosis strain. This transfer was then followed by the integration of ICEEc2 into the host chromosome downstream of a phe tRNA gene. Our data indicated that this transfer involved a set of three genes encoding DNA mobility enzymes and a type IV pilus encoded by genes present on ICEEc2. Given the wide distribution of members of this family, these mobile genetic elements are likely to play an important role in the diversification of bacteria.The fantastic diversity of the Escherichia coli species has been known for a long time. With modern sequencing strategies, the molecular bases of this diversity are now being unraveled (49). Analyzing the genome of 20 E. coli strains, Touchon et al. recently showed that only a minority of genes, approximately 1,900 genes, were shared by all E. coli strains and constituted the core genome of the E. coli species (50). Additionally, the total number of genes found in all E. coli strains, the pan-genome, is an order of magnitude larger than this core genome (50). The non-core genome of a strain, also called flexible gene pool, is therefore made of a wide diversity of genes. This genetic diversity of the E. coli species translates into a diversity of phenotypic properties. While most E. coli strains are commensal of the gastrointestinal tract of humans and warm-blooded animals, a significant number are responsible for different diseases in humans and animals (22), including extraintestinal infections in chickens; strains isolated from such cases are designated by the term APEC for avian pathogenic E. coli (10).This diversity arises from frequent horizontal gene transfers of mobile genetic elements such as transposons, plasmids, phages, genomic islands, or integrative and conjugative elements (ICEs) (11, 21, 34). Among these mobile genetic elements, ICEs have a particular place as they share properties with both plasmids, genomic islands, and transposons; they can be defined as elements that encode all the necessary machineries that allow their excision from the chromosome, their transfer to a recipient strain, and their integration into the recipient strain''s genome (5, 6, 46, 54). Well-known representatives of this class of genetic elements include Tn916 discovered in Enterococcus faecalis, the conjugative transposon CTnDOT in Bacteroides thetaiotaomicron, ICEKp1 in Klebsiella pneumoniae, SXT/R391-related elements, PFGI-1 in Pseudomonas fluorescens, and the clc element in Pseudomonas sp. strain B13 as well as ICEBs1 in Bacillus subtilis and ICEEc1 in the E. coli strain ECOR31 (1, 39, 44, 46, 54). Typically, ICEs contain at least three modules that are required for key steps in the ICE''s life cycle: an excision/integration module, a transfer module, and a regulation module (54). Besides these, ICEs often contain cargo regions that confer on their host a diverse array of properties, such as virulence properties (ICEEc1), antibiotic resistance (SXT), or degradation of chemical compounds (clc). Because of their self-transfer abilities and their diverse accessory gene repertoires, ICEs are very likely to play a major role in bacteria evolution (46).A new family of ICEs has recently gained interest and was named the pKLC102/PAGI-2 family. The first element of this family, the clc element, was discovered in Pseudomonas sp. strain B13 and confers on the bacteria the possibility to degrade aromatic compounds (42). The transfer of this element was discovered long before its complete sequence was characterized (16). Other members of this family include several elements present in Pseudomonas strains such as PAGI-1 and PAGI-2 as well as the pKLC102 element first considered to be a plasmid but later on shown to be an ICE because of its ability to integrate into the chromosome of its host (23, 52). pKLC102/PAGI-2 elements share a set of core genes (33) and, like most ICEs and genomic islands, are all integrated downstream of tRNA genes (26, 52). The transfer between strains has been demonstrated, albeit with different frequencies, for only a few members, such as the clc element, Pseudomonas aeruginosa pathogenicity island 1 (PAPI-1), and ICEHin1056 from Haemophilus influenzae (20, 37, 41); this transfer involves the type IV pilus (20), the integrase (40), and in some cases the formation of a circular intermediate of the excised ICE (24).In order to identify new accessory genes of APEC strains, we previously described tRNA loci in the E. coli genome that could represent potential insertion sites for new genomic islands (18). We had already used this strategy to characterize the AGI-3 region that is involved in the virulence of an avian pathogenic E. coli strain and that confers the ability to grow on fructooligosaccharides (7, 43). During this tRNA screening, we showed that genomic islands might potentially be present downstream of the tRNA genes argW, leuX, pheU, pheV, selC, serU, and thrW in several APEC strains.In this report, we describe the identification of a new genomic island located downstream of pheU in the APEC strain BEN374. This region, which we named ICEEc2, was fully sequenced, and its properties were analyzed in detail; ICEEc2 is a new ICE found in E. coli and belongs to the pKLC102/PAGI-2 family described above.     

Age-associated adipose tissue inflammation promotes monocyte chemotaxis and enhances atherosclerosis

Although aging enhances atherosclerosis, we do not know if this occurs via alterations in circulating immune cells, lipid metabolism, vasculature, or adipose tissue. Here, we examined whether aging exerts a direct pro-atherogenic effect on adipose tissue in mice. After demonstrating that aging augmented the inflammatory profile of visceral but not subcutaneous adipose tissue, we transplanted visceral fat from young or aged mice onto the right carotid artery of Ldlr^−/− recipients. Aged fat transplants not only increased atherosclerotic plaque size with increased macrophage numbers in the adjacent carotid artery, but also in distal vascular territories, indicating that aging of the adipose tissue enhances atherosclerosis via secreted factors. By depleting macrophages from the visceral fat, we identified that adipose tissue macrophages are major contributors of the secreted factors. To identify these inflammatory factors, we found that aged fat transplants secreted increased levels of the inflammatory mediators TNFα, CXCL2, and CCL2, which synergized to promote monocyte chemotaxis. Importantly, the combined blockade of these inflammatory mediators impeded the ability of aged fat transplants to enhance atherosclerosis. In conclusion, our study reveals that aging enhances atherosclerosis via increased inflammation of visceral fat. Our study suggests that future therapies targeting the visceral fat may reduce atherosclerosis disease burden in the expanding older population.     

Sequence-based classification of type II polyketide synthase biosynthetic gene clusters for antiSMASH

Journal of Industrial Microbiology & Biotechnology - The software antiSMASH examines microbial genome data to identify and analyze biosynthetic gene clusters for a wide range of natural...     

Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP

Negative regulation of mitogenic pathways is a fundamental process that remains poorly characterized. The angiotensin II AT2 receptor is a rare example of a 7-transmembrane domain receptor that negatively cross-talks with receptor tyrosine kinases to inhibit cell growth. In the present study, we report the molecular cloning of a novel protein, ATIP1 (AT2-interacting protein), which interacts with the C-terminal tail of the AT2 receptor, but not with those of other receptors such as angiotensin AT1, bradykinin BK2, and adrenergic beta(2) receptor. ATIP1 defines a family of at least four members that possess the same domain of interaction with the AT2 receptor, contain a large coiled-coil region, and are able to dimerize. Ectopic expression of ATIP1 in eukaryotic cells leads to inhibition of insulin, basic fibroblast growth factor, and epidermal growth factor-induced ERK2 activation and DNA synthesis, and attenuates insulin receptor autophosphorylation, in the same way as the AT2 receptor. The inhibitory effect of ATIP1 requires expression, but not ligand activation, of the AT2 receptor and is further increased in the presence of Ang II, indicating that ATIP1 cooperates with AT2 to transinactivate receptor tyrosine kinases. Our findings therefore identify ATIP1 as a novel early component of growth inhibitory signaling cascade.